There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The efficacy and toxicity of bendamustine chemotherapy in relapsed small cell lung
cancer (SCLC) was determined in this phase II trial.